LP-002-09

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameLP-002-09
Drug Alias NameLP-00209LP-002-09
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMast cells stabilizers
TargetsNot applicable
Therapy Area/IndicationsConjunctivitis, Allergic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesLaila Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLaila Pharmaceuticals
Active IndicationsN/A
Inactive IndicationsConjunctivitis, Allergic

Other Information

ATC CodeN/A
Related LinksN/A